Early-Stage drug safety study in healthy people halted
NCT ID NCT03977974
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study aimed to check the safety and side effects of an experimental drug called LY3526318 in healthy adults. It was a Phase 1 trial with two parts, lasting up to 51 days total. The study was terminated early, and no results are available. It involved 76 healthy participants and focused on measuring how the drug moves through the body and any serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
PRA Health Sciences
Groningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.